How are you proposing CHM create allogenic T cells? By their very nature, they are autologous and cause GvHD if given to anyone else other than the patient. For them to be truely Allogeneic they need to go through major gene editing, there for what does this do to the cost of production?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $10.07M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $54.41K | 10.88M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 45 | 32072317 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 127011 | 3 |
View Market Depth
| Last trade - 15.54pm 21/07/2025 (20 minute delay) ? |
| CHM (ASX) Chart |